618O - Health-related quality of Life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR)
| Autor: | Vogel, A., Qin, S., Kudo, M., Hudgens, S., Yamashita, T., Yoon, J-H., Fartoux, L., Simon, K., López López, C., Sung, M., Dutcus, C., Kraljevic, S., Tamai, T., Grunow, N., Meier, G., Breder, V. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v210-v210 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|